Grown Rogue International (GRUSF) Profit After Tax Growth (1y) (2010 - 2026)
Grown Rogue International (GRUSF) Profit After Tax Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | -303.53% |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | -5.04% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -17.27% |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 7.59% |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | -2,482.61% |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 34.32% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 390.91% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Grown Rogue International | 110.47 Mn | 98.93 Mn | 5.37 Mn | -202.26% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -202.26% |
| Mar 31, 2026 | -463.75% |
| Dec 31, 2025 | -143.01% |
| Sep 30, 2025 | 524.91% |
| Jun 30, 2025 | 125.64% |
| Mar 31, 2025 | 117.83% |
| Dec 31, 2024 | 1,845,069,479.40% |
| Jan 31, 2023 | 281.20% |
| Jan 31, 2022 | 115.61% |
| Oct 31, 2021 | 1,000.76% |
| Jul 31, 2021 | 130.26% |
| Apr 30, 2021 | -19.53% |
| Jan 31, 2021 | -527.03% |
| Oct 31, 2020 | 99.27% |
| Jul 31, 2020 | 14.72% |
| Apr 30, 2020 | -173.21% |
| Jan 31, 2020 | 104.86% |
| Oct 31, 2019 | -34.76% |
| Jul 31, 2019 | -163.76% |
| Apr 30, 2019 | 50.23% |